AIMC Topic: Carcinoma, Ductal, Breast

Clear Filters Showing 21 to 30 of 40 articles

Volumetric breast density estimation on MRI using explainable deep learning regression.

Scientific reports
To purpose of this paper was to assess the feasibility of volumetric breast density estimations on MRI without segmentations accompanied with an explainability step. A total of 615 patients with breast cancer were included for volumetric breast densi...

Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses.

Diagnostic pathology
BACKGROUND: The mitotic count in breast carcinoma is an important prognostic marker. Unfortunately substantial inter- and intra-laboratory variation exists when pathologists manually count mitotic figures. Artificial intelligence (AI) coupled with wh...

A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.

Breast cancer research : BCR
BACKGROUND: For breast cancer patients undergoing neoadjuvant chemotherapy (NAC), pathologic complete response (pCR; no invasive or in situ) cannot be assessed non-invasively so all patients undergo surgery. The aim of our study was to develop and va...

Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.

Breast cancer research : BCR
BACKGROUND: Distinguishing ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC) regions in clinical biopsies constitutes a diagnostic challenge. Spatial transcriptomics (ST) is an in situ capturing method, which allows quantification ...

Deep learning analysis of breast MRIs for prediction of occult invasive disease in ductal carcinoma in situ.

Computers in biology and medicine
PURPOSE: To determine whether deep learning-based algorithms applied to breast MR images can aid in the prediction of occult invasive disease following the diagnosis of ductal carcinoma in situ (DCIS) by core needle biopsy.

Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence Score.

Journal of magnetic resonance imaging : JMRI
BACKGROUND: Oncotype Dx is a validated genetic analysis that provides a recurrence score (RS) to quantitatively predict outcomes in patients who meet the criteria of estrogen receptor positive / human epidermal growth factor receptor-2 negative (ER+/...